Home
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Michele C. Bosch
Michele C. Bosch
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
A Look At AIA § 3(n)(2): Part Two Of A Two-Part Series On AIA § 3(n) Effective Filing Date Provisions
28 Sep 2021 | United States
AIA § 3(n) Effective Filing Date Provisions Part I: A Look At PGR Eligibility
26 Jul 2021 | United States
A Look At PGR Eligibility Under AIA § 3(n)(1): Part One Of A Two-Part Series On AIA §§ 3(n) Effective Filing Date Provisions
19 Jul 2021 | United States
Fruit Of One's Label: A Review Of Three Key Federal Circuit Wins
17 Mar 2021 | United States
Got Pharmaceutical Means-Plus-Function Claims?
18 Aug 2020 | United States
Proposed Revisions To Form 3542 With Explanations
10 Jul 2020 | United States
A Belated Lesson In How To Avoid A Finding Of Obviousness Based Upon Inherent Disclosure
14 Jan 2020 | United States
The Boston Manifesto
15 Oct 2019 | United States
The Amazing Story Of The Unsinkable Claim 8: How Many Lives Does A Patent Claim Have?
19 Jul 2019 | United States
When Is A Broken Record Not A Broken Record?
19 Jul 2019 | United States
Double The Trouble: Lack Of Priority Opens The Door To Unpatentability In An IPR Proceeding
19 Jul 2019 | United States
A Tale Of Two Supplemental Examinations, Part II: Surprising Events When Citing Art That, But For A Clerical Error, Would Have Been Cited During Original Prosecution
24 Jun 2019 | United States
A Tale Of Two Supplemental Examinations: Part 1: Unraveling Confusion
18 Jun 2019 | United States
When Will They Ever Learn? Subject Matter Disclosed In The Patent Specification But Never Claimed Is Dedicated To The Public
07 Jun 2019 | United States
Only Having The Pieces Of A Jigsaw Puzzle Isn't Enough - They Have To Be Assembled Together
13 Mar 2019 | United States
Combine the Label with Phase III Clinical Results and a Carefully Crafted, Mirroring US Patent Application to Achieve Longer Patent Exclusivity for US Life Science Patents
02 Jan 2019 | United States
Coming Full Circle From Seagate To Halo On Invalidity Opinions
27 Feb 2018 | United States
Derivation: Possession Versus Conception
22 Sep 2014 | United States
Demystifying IP Due Diligence
19 Jul 2006 | United States
Contact Details
Washington, DC
Email Website
901 New York Avenue, NW
Washington, DC
United States
Telephone: 1-202-4084000

  © Mondaq® Ltd 1994 - 2022. All Rights Reserved.